Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China

To increase the capacity of identifying coronavirus disease 2019 (COVID-19) infection, many Biosafety Level 2 (BSL-2) labs have been established in a short period of time for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid tests all over the world. However, their biosafety...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Dan, Gao, Wenfeng, Liang, Shu, Yang, Shujuan, Jia, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359782/
https://www.ncbi.nlm.nih.gov/pubmed/32768807
http://dx.doi.org/10.1016/j.envint.2020.105964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359782/
https://www.ncbi.nlm.nih.gov/pubmed/32768807
http://dx.doi.org/10.1016/j.envint.2020.105964

Ejemplares similares